Thymosin Alpha-1
Research use only.
High-purity research-grade Thymosin Alpha-1
Thymosin Alpha-1 (Tα1) is a naturally derived immune-modulating peptide widely studied for its role in enhancing immune system function, regulating inflammatory responses, and supporting host defense mechanisms. Originally isolated from thymic tissue, it is commonly explored in research involving immune restoration, antiviral defense, and immune system balance in states of dysfunction or suppression.
Product overview
Thymosin Alpha-1 is a 28-amino-acid peptide produced naturally in the thymus gland and involved in the maturation and differentiation of T-cells. Research involving Tα1 has focused on its ability to enhance innate and adaptive immune responses by modulating dendritic cell activity, T-cell function, and cytokine production. It is widely studied in immunology, infectious disease, and immune aging research models.
Key research features
Supports immune system function: Studies indicate Thymosin Alpha-1 may enhance T-cell mediated immunity and improve overall immune responsiveness. This makes it a key compound in research on immune deficiency and immune modulation.
Antiviral and host defense research: Research suggests Tα1 may enhance the body’s ability to respond to viral challenges by improving immune signaling pathways and supporting balanced cytokine responses in experimental models.
Inflammation regulation: Thymosin Alpha-1 has been investigated for its role in modulating inflammatory cytokines, potentially helping maintain immune homeostasis and preventing excessive immune activation.
Immune restoration and aging research: Early studies indicate Tα1 may help restore immune function in models of immunosenescence, where thymic activity and immune responsiveness decline with age.
Thymosin Alpha-1 Suggested Use:
Typical Dose: 1.6–3.2 mg per day
Route: Subcutaneous injection
Frequency: Once daily or 2–3 times weekly depending on research protocol
Duration: 4–8 weeks, or as recommended by a healthcare professional